Literature DB >> 15194446

Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor.

Vincent Giguère1, Maxime A Gallant, Artur J de Brum-Fernandes, Jean-Luc Parent.   

Abstract

Prostacyclin activation of prostanoid IP receptors may result in pain sensation, inflammatory responses, inhibition of platelet aggregation, and vasodilation in vascular tissue. The prostanoid IP receptor is a G-protein-coupled receptor. In the present study, we investigated the determinants responsible, at least in part, for the prostacyclin receptor (IP) dimerization/oligomerization. Using co-immunoprecipitation of differentially tagged IP expressed in COS-7 cells, we demonstrate that IP can form dimers and oligomers. Treatment of IP-expressing cells with the stable agonist carbaprostacyclin failed to alter the ratios of oligomeric/dimeric/monomeric forms of the receptor, suggesting that IP dimerization/oligomerization is an agonist-independent process. The reducing agents dithiothreitol and 2-mercaptoethanol were highly efficient in converting the receptor from its oligomeric form to the monomeric state, indicating the involvement of disulfide bonds in IP oligomerization. Immunoblotting of the osteoblastic MG-63 cell line lysates with an anti-IP specific antibody revealed the presence of endogenous IP oligomers which were converted to dimers and monomers upon treatment with dithiothreitol. Individual substitutions of the four extracellular IP Cys residues (Cys(5), Cys(92), Cys(165) and Cys(170)) for Ser resulted in greatly decreased receptor protein expression in COS-7 cells. The C92-170S double mutant showed receptor protein expression level similar to the individual mutants. However, expression of the C92-165S and C165-170S mutants was drastically reduced, suggesting that there was formation of disulfide bonds between Cys(5) and Cys(165), and between Cys(92) and Cys(170). The Cys receptor mutants showed altered oligomer/dimer/monomer ratios. Dimerization/oligomerization likely occurs intracellularly since these Cys receptor mutants could still form dimers/oligomers despite their lack of expression at the cell surface.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194446     DOI: 10.1016/j.ejphar.2004.04.041

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor.

Authors:  Damien Thévenin; Tzvetana Lazarova; Matthew F Roberts; Clifford R Robinson
Journal:  Protein Sci       Date:  2005-06-29       Impact factor: 6.725

2.  BRI2 homodimerizes with the involvement of intermolecular disulfide bonds.

Authors:  Maria Tsachaki; Jorge Ghiso; Agueda Rostagno; Spiros Efthimiopoulos
Journal:  Neurobiol Aging       Date:  2008-04-28       Impact factor: 4.673

3.  Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport.

Authors:  Gabriella A Papale; Paul J Hanson; Daisy Sahoo
Journal:  Biochemistry       Date:  2011-06-24       Impact factor: 3.162

4.  Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease.

Authors:  Salam Ibrahim; Mazell Tetruashvily; Alex J Frey; Stephen J Wilson; Jeremiah Stitham; John Hwa; Emer M Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-03       Impact factor: 8.311

Review 5.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

Review 6.  Prostacyclin receptor regulation--from transcription to trafficking.

Authors:  C Midgett; J Stitham; K A Martin; J Hwa
Journal:  Curr Mol Med       Date:  2011-10       Impact factor: 2.222

7.  RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.

Authors:  Keith R Bley; Anindya Bhattacharya; Don V Daniels; Joel Gever; Alam Jahangir; Counde O'Yang; Steven Smith; Dinesh Srinivasan; Anthony P D W Ford; Mary-Frances Jett
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

8.  Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.

Authors:  Adolfo Rivero-Müller; Yen-Yin Chou; Inhae Ji; Svetlana Lajic; Aylin C Hanyaloglu; Kim Jonas; Nafis Rahman; Tae H Ji; Ilpo Huhtaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

9.  Conserved extracellular cysteine residues and cytoplasmic loop-loop interplay are required for functionality of the heptahelical MLO protein.

Authors:  Candace Elliott; Judith Müller; Marco Miklis; Riyaz A Bhat; Paul Schulze-Lefert; Ralph Panstruga
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.